Market Signal Briefing

November 08, 2025 1:14 AM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - November 8, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of V.F. Corporation (NYSE: VFC) between October 30, 2023 and May 20, 2025, both dates inclusive (the "Class Period"), of the important November 12, 2025 lead plaintiff deadline.

SO WHAT: If you purchased V.F. Corporation securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the V.F. Corporation class action, go to https://rosenlegal.com/submit-form/?case_id=44811 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 12, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants disseminated materially false and misleading statements and/or concealed material adverse facts concerning the true state of V.F. Corporation's turnaround plans. Specifically, defendants provided investors with material information concerning V.F. Corporation's turnaround plan ("Reinvent"), which in part focused on efforts to return the Vans brand to positive growth. The lawsuit alleges that defendants concealed that additional significant reset actions would be necessary to return the Vans brand to growth, and would result in significant setbacks to Vans' revenue growth trajectory. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the V.F. Corporation class action, go to https://rosenlegal.com/submit-form/?case_id=44811 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/273691

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lantheus To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Lantheus between February 26, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

, /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) and reminds investors of the November 10, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi & Faruqi, LLP)

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

According to the complaint, defendants provided investors with misleading statements concerning the true state of Pylarify's competitive position; notably, that Lantheus was not equipped to properly assess the pricing and competitive dynamics for Pylarify, risking Pylarify's price point, revenue, and overall growth potential. These statements caused Plaintiff and other shareholders to purchase Lantheus' securities at artificially inflated prices.

Investors began to question the veracity of Defendants' public statements on May 7, 2025, when Lantheus reported its first quarter results below market expectations with Pylarify's performance particularly falling short. Then, on August 6, 2025, Lantheus again announced disappointing results and significantly reduced growth expectations for Pylarify, which had fallen 8.3% year-over-year, and slashed fiscal year 2025 growth projections. Defendants attributed the losses to the ongoing competition, impacting Pylarify's pricing dynamics.

Investors and analysts reacted promptly to Lantheus' revelations. The price of Lantheus' common stock declined dramatically. From a closing market price of $72.83 per share on August 5, 2025, Lantheus' stock price fell to $51.87 per share on August 6, 2025, a decline of about 28.8% in the span of one day.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. 

Faruqi & Faruqi, LLP also encourages anyone with information regarding Lantheus' conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Lantheus Holdings, Inc. class action, go to www.faruqilaw.com/LNTH or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Synopsys To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Synopsys between December 4, 2024 and September 9, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

, /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Synopsys, Inc. ("Synopsys" or the "Company") (NASDAQ: SNPS) and reminds investors of the December 30, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi & Faruqi, LLP)

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the extent to which the Company's increased focus on artificial intelligence customers, which require additional customization, was deteriorating the economics of its Design IP business; (2) that, as a result, "certain road map and resource decisions" were unlikely to "yield their intended results;" (3) that the foregoing had a material negative impact on financial results; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On September 9, 2025, after market hours, Synopsys released its third quarter 2025 financial results, revealing the Company's "IP business underperformed expectations." The Company reported quarterly revenue of $1.740 billion, missing its prior guidance of between $1.755 billion and $1.785 billion, and reported net income of $242.5 million, a 43% year-over-year decline from $425.9 million reported for third quarter 2024. Moreover, the Company reported its Design IP segment accounted for approximately 25% of revenue and came in at $426.6 million, a 7.7% decline year-over-year. Finally, management provided guidance which implied that Design IP revenues will decline by at least 5% on a full-year basis in fiscal 2025.

On this news, Synopsys's stock price fell $216.59, or 35.8%, to close at $387.78 per share on September 10, 2025, on unusually heavy trading volume.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. 

Faruqi & Faruqi, LLP also encourages anyone with information regarding Synopsys' conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Synopsys class action, go to www.faruqilaw.com/SNPS or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE Faruqi & Faruqi, LLP

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson  Encourages Investors Who Suffered Significant Losses In Stride To Contact Him Directly To Discuss Their Options

If you suffered significant losses in Stride stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). 

[You may also click here for additional information]

, /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Stride, Inc. ("Stride" or the "Company") (NYSE: LRN).

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi & Faruqi, LLP)

On September 14, 2025, Simply Wall St. published a report stating that the Gallup-McKinley County Schools Board of Education had filed a complaint against Stride, alleging fraud, deceptive trade practices, systemic violations of law, and intentional and tortious misconduct, including inflating enrollment numbers by retaining "ghost students" on rolls to secure state funding per student and ignoring compliance requirements, including background checks and licensure laws for its employees.

On this news, Stride's stock price fell $18.60, or 11.7%, to close at $139.76 per share on September 15, 2025, thereby injuring investors.

Then, on October 28, 2025, Stride released its first quarter fiscal 2026 financial results, revealing the Company had purposely "limit[ed] enrollment growth while we improve our execution." The Company also revealed it had experienced "system implantation issues" resulting in "higher withdrawal rates and lower conversion rate." The Company stated that "these factors resulted in approximately 10,000 to 15,000 fewer enrollments" and "these challenges will likely restrict [its] in-year enrollment growth."

On this news, Stride's stock price fell as much as 51% during intraday trading on October 29, 2025, thereby injuring investors further.

To learn more about the Stride investigation, go to www.faruqilaw.com/LRN or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In KBR To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in KBR between May 6, 2025 and June 19, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

, /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against KBR, Inc. ("KBR" or the "Company") (NYSE: KBR) and reminds investors of the November 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi & Faruqi, LLP)

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Despite the knowledge that the U.S. Department of Defense's Transportation Command (TRANSCOM) had, for months, had material concerns with HomeSafe's ability to fulfill the Global Household Goods Contract, defendants claimed that the partnership was without issue, and would ramp up in future quarters; and (2) as a result, defendants statements about KBR's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

On June 19, 2025, after the market closed, HomeSafe issued a press release entitled "HomeSafe Alliance announces TRANSCOM's Notice to Terminate Global Household Goods Contract." The next day, before market hours, KBR issued a press release entitled "KBR Announcement on HomeSafe Alliance Global Household Goods Contract."

On this news, the price of KBR stock fell $3.85 per share, or 7.29%, to close at $48.93 on June 20, 2025. On June 23, 2025, the next trading day, KBR stock fell a further $1.30, or 2.65%, to close at $47.63 on June 23, 2025.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. 

Faruqi & Faruqi, LLP also encourages anyone with information regarding KBR's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the KBR class action, go to www.faruqilaw.com/KBR or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE Faruqi & Faruqi, LLP

Item 1 of 2 A bottle of Don Julio, tequila from Diageo, the world's leading spirits maker, is displayed at a liquor store, in Monterrey, Mexico, December 10, 2024. REUTERS/Daniel Becerril

[1/2]A bottle of Don Julio, tequila from Diageo, the world's leading spirits maker, is displayed at a liquor store, in Monterrey, Mexico, December 10, 2024. REUTERS/Daniel Becerril Purchase Licensing Rights, opens new tab

CompaniesNov 8 (Reuters) - Diageo

(DGE.L), opens new tab, the world's top spirits maker, has considered external candidates to be its chief executive, including outgoing GSK

(GSK.L), opens new tab CEO Emma Walmsley, the Financial Times reported on Saturday, citing people familiar with the situation.

Diageo and GSK did not immediately respond to Reuters requests for comment.

Sign up here.

In September, GSK said Walmsley would step down at the end of the year and be replaced by insider Luke Miels. Walmsley served for more than eight years in the role, making her the most senior female CEO in Britain.

Interim Diageo CEO Nik Jhangiani stepped in after the abrupt exit of former CEO Debra Crew in July, after she struggled to win over investors following a bumpy start to her tenure.

Jhangiani previously said he expected a decision on a permanent replacement by the end of October, but the company did not provide an update when it cut its sales and profit forecasts on Thursday.

Cranley Macfarlane, deputy chief investment officer at Diageo investor Church House Investments, said this raised questions about why Jhangiani had not been made CEO on a permanent basis, as some had expected.

On Thursday, Diageo said it expected 2026 sales to be "flat to slightly down" with only low- to mid-single-digit operating profit growth.

Diageo is attempting to cut costs and sell assets as the drinks industry faces cooling post-pandemic demand, tariff-related uncertainty and shifting consumer habits

Reporting by Rishabh Jaiswal in Bengaluru; Editing by William Mallard and Thomas Derpinghaus

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Jasper To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Jasper between November 30, 2023 and July 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

, /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ: JSPR) and reminds investors of the November 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi & Faruqi, LLP)

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) Jasper lacked the controls and procedures necessary to ensure that the third-party manufacturers on which it relied were manufacturing products in full accordance with cGMP regulations and otherwise suitable for use in clinical trials; (ii) the foregoing failure increased the risk that results of ongoing studies would be confounded, thereby negatively impacting the regulatory and commercial prospects of the Company's products, including briquilimab; (iii) the foregoing increased the likelihood of disruptive cost-reduction measures; (iv) accordingly, the Company's business and/or financial prospects, as well as briquilimab's clinical and/or commercial prospects, were overstated; and (v) as a result, Defendants' public statements were materially false and misleading at all relevant times.

On July 7, 2025, Jasper issued a press release reporting updated data from the BEACON Study. The press release stated that "[r]esults from the 240mg Q8W and the 240mg followed by 180mg Q8W dose cohorts appear to be confounded by an issue with one drug product lot used in those cohorts, with 10 of the 13 patients dosed with drug from the lot in question," that "[t]he Company is investigating the drug product lot in question and expects to have the results of that investigation in the coming weeks," and that Jasper was "taking steps to ensure that drug product from the lot in question is returned to the Company and that sites have drug product from other lots to continue dosing." Further, the press release revealed that the Company "has also determined that the drug product lot in question was used to treat participants enrolled in the ETESIAN [Study]. As a result, and in order to focus resources on advancing briquilimab in CSU, the Company is halting the study and pausing development in asthma." Finally, the press release stated that "the Company is halting development in SCID" and, contrary to its prior representation of having a strong balance sheet and a cash runway extending "through the third quarter of 2025," that Jasper "will be implementing a number of other cost cutting measures including a potential restructuring, to extend runway and reduce expenses."

On this news, Jasper's stock price fell $3.73 per share, or 55.1%, to close at $3.04 per share on July 7, 2025.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. 

Faruqi & Faruqi, LLP also encourages anyone with information regarding Jasper's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Jasper Therapeutics, Inc. class action, go to www.faruqilaw.com/JSPR or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE Faruqi & Faruqi, LLP

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In James Hardie To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in James Hardie between May 20, 2025 and August 18, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

, /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against James Hardie Industries plc ("James Hardie" or the "Company") (NYSE: JHX) and reminds investors of the December 23, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi & Faruqi, LLP)

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that James Hardie Industries plc misled investors about the strength of its key North America Fiber Cement segment between May 20 and August 18, 2025. Despite knowing by April and early May that distributors were destocking inventory, the company falsely claimed demand remained strong and that stock levels were "normal."

On August 19, 2025, James Hardie issued a press release announcing financial results for its first quarter ended June 30, 2025. Among other items, James Hardie reported a 29% decline in first-quarter profit and projected lower-than-expected fiscal 2026 earnings, citing high borrowing costs.

On this news, James Hardie's American Depositary Receipt ("ADR") price fell $9.79 per ADR, or 34.44%, to close at $18.64 per ADR on August 20, 2025.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. 

Faruqi & Faruqi, LLP also encourages anyone with information regarding James Hardie's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the James Hardie class action, go to www.faruqilaw.com/JHX or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Cytokinetics between December 27, 2023 and May 6, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

, /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) and reminds investors of the November 17, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi & Faruqi, LLP)

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

According to the complaint, defendants made materially false and misleading statements regarding the timeline for the New Drug Application ("NDA") submission and approval process for aficamten. Specifically, defendants represented that the Company expected approval from the U.S. Food and Drug Administration ("FDA") for its NDA for aficamten in the second half of 2025, based on a September 26, 2025 PDUFA date, and failed to disclose material risks related to the Company's failure to submit a Risk Evaluation and Mitigation Strategy ("REMS") that could delay the regulatory process.

On May 6, 2025, during an earnings call, it was revealed that the Company had multiple pre-NDA meetings with the FDA discussing safety monitoring and risk mitigation but chose to submit the NDA without a REMS, relying on labeling and voluntary education materials. This confirmed defendants' awareness of potential REMS requirements and their reckless decision to omit it from the initial submission, misleading investors about the regulatory timeline.

As a result of defendants' false and misleading statements, class members purchased Cytokinetics' common stock at artificially inflated prices and suffered significant losses when the truth was revealed.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. 

Faruqi & Faruqi, LLP also encourages anyone with information regarding Cytokinetics' conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Cytokinetics, Incorporated class action, go to www.faruqilaw.com/CYTK or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE Faruqi & Faruqi, LLP

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

The potential approval of the XRP ETF could significantly boost institutional interest and investment in the cryptocurrency market. 21Shares XRP ETF 20-day countdown begins after new SEC filing.

Financial author Robert Kiyosaki has renewed his call for individuals to protect their wealth using Bitcoin (BTC) and Ethereum (ETH), describing them as the “last defense of financial freedom.” His comments come amid growing concerns about the political and economic trajectory of the United States.

Institutional investors respond to market volatility as large asset managers adjust digital asset portfolios.

Key Takeaways

BlackRock clients divested $127 million in Bitcoin on November 7.
This marks another major outflow from the asset manager's crypto holdings.

BlackRock clients pulled $127 million from the firm’s Bitcoin ETF on Friday, marking another sizable outflow from the asset manager’s cryptocurrency holdings.

BlackRock, a prominent asset manager, has experienced a series of Bitcoin outflows in recent periods, raising questions about shifting institutional sentiment toward crypto assets.

Investors are monitoring BlackRock’s asset transfers to exchanges as potential indicators of broader market adjustments. Other major asset managers have also reported client-driven Bitcoin sales, reflecting portfolio rebalancing in volatile conditions.

Disclaimer

Bitcoin's $100,000 line is not a victory lap anymore — it is a stress test. Mike McGlone of Bloomberg Intelligence says what is happening now looks a lot like what happens before a market breaks.

The race to bring altcoins into the mainstream investment world just took a serious turn. The world’s first & largest crypto ETP issuer, 21Shares, just filed Amendment No. 3, moving one step closer to launching the first-ever spot XRP ETF in the U.S.

If the SEC doesn’t step in within the next 20 days, the fund could get automatic approval by November 27. 

On November 7, 2025, 21Shares filed Amendment No. 3 to its S-1 form with the U.S. Securities and Exchange Commission (SEC). This filing triggers a 20-day review period, during which the SEC can either respond or let the ETF go live automatically by November 27.

Bloomberg’s senior ETF analyst Eric Balchunas pointed out that if the SEC stays silent, 21Shares’ spot XRP ETF will be automatically approved. That’s a huge development, especially since XRP has long struggled for regulatory recognition in the U.S.

Other Firms Join the XRP ETF RaceThis move didn’t happen in isolation. Right before 21Shares’ filing, institutional giants like Franklin Templeton, Grayscale, and Bitwise made similar amendments to their own ETF applications. 

Each of these filings restarts a short approval countdown, signaling a growing wave of optimism for altcoin ETFs.

WisdomTree Files for CoinDesk 20 ETFBut that’s not all. Meanwhile, WisdomTree took things further by filing for a Physical CoinDesk 20 Spot ETF, a diversified fund tracking the top 20 cryptocurrencies by market cap.

This ETF will offer investors exposure to a diverse basket including Bitcoin (31.02%), XRP (19.60%), Ethereum, Cardano, Solana, and others.

WisdomTree files for CoinDesk 20 ETF…

Will hold 20 largest digital assets by market cap that are eligible for inclusion in index.

It's clear CoinDesk aggressively seeking to position w/in crypto indexing space (which I think will be massive). pic.twitter.com/sqBHEzs4n7

— Nate Geraci (@NateGeraci) November 7, 2025 From Legal Victory to Wall Street MomentumEver since Ripple’s 2023 legal win against the SEC, institutional interest in XRP has surged. Analysts like Nate Geraci believe this marks the beginning of a new phase, where altcoins can finally compete on Wall Street without regulatory fear.

Still, uncertainty remains. The SEC could step in, delay, or deny. But if it doesn’t, 21Shares’ XRP ETF could make history.

Following this announcement, the XRP price has seen a jump of 4%, trading around $2.32, with a market cap of $139.19 billion.  

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

When Elon Musk crosses the trillion-dollar threshold, it will mark more than personal success. It will signal a new phase in economic history, where individual influence rivals that of entire states.

As a Bitcoiner, I see Satoshi Nakamoto’s vision of decentralized wealth and democratized finance as a blueprint for diffusing power, a way to make value less dependent on singular actors.

Yet as capital, AI, and policy orbit Musk’s expanding empire, his rise exposes how far we’ve strayed from that ethos.

The very idea of “value” may be consolidating again, this time not in governments or banks, but in individuals who wield technology as a form of leverage.

Some would say Bitcoin embodies the purest form of private property: unconfiscable, borderless, self-sovereign.

From that angle, Satoshi might not have viewed a trillionaire as a failure of decentralization but as its logical, perhaps unintended, consequence.

Elon’s elaborate paydayAs of today, Tesla shareholders have approved a compensation package that could potentially increase Elon Musk’s net worth to $1 trillion if the plan’s milestones are met.

More than 75 percent of votes at Tesla’s Nov. 6 annual meeting backed a multiyear, option-heavy plan that pays out only if Tesla clears operational and valuation hurdles, including a market capitalization of nearly $8.5 trillion and the deployment of large-scale autonomy and humanoid robotics.

The math embedded in Tesla’s plan sets up an unusual comparison: a single individual’s equity exposure can plausibly overtake the market cap of the top four altcoins combined.

How to reach the finish line: wealth, power, and policyIf all of Musk’s tranches vest and are exercised, his effective ownership could move into the mid-20s percent, subject to dilution and financing.

At $8.5 trillion, a 27 percent stake would be approximately $2.295 trillion from Tesla alone. SpaceX is valued at nearly $350 billion in private markets as of mid-2025, with published bull cases reaching the trillions by 2030 in defense and broadband.

xAI funding chatter has circulated in a $75 to $200 billion range. Layered together, the convexity of the option grant ties personal wealth to a small set of binary outcomes, above all, robotaxis and humanoid robots.

Those are policy-gated as much as they are technical. In California, Tesla holds a DMV permit for testing with a safety driver, not the driverless testing and deployment permits that unlock commercial-scale operations. Separate CPUC approvals govern the phases of ride service, according to state records and Reuters coverage.

NHTSA’s scrutiny of Full Self Driving features remains a headline risk, as seen in prior probes covered by Ars Technica.

The trillion-dollar crypto challenge in perspectiveCurrently, Elon Musk’s net worth exceeds that of any single altcoin network. Only Bitcoin has a higher market cap at over $2 trillion, and I’m bullish enough on BTC to believe it will continue to outperform the portfolio of any private individual.

The next highest, Ethereum, has a market cap that has fluctuated in a $390 to $600 billion range in recent months, currently sitting at around $400 billion, which is around $100 billion below Musk’s wealth.

So let’s do some basic forward modeling.

Under a conservative scenario where autonomy is delayed and Optimus remains niche, Tesla reaches a valuation of $3 trillion by 2035, yielding approximately $750 billion for Musk’s 25 percent stake in Tesla, with SpaceX at $500 billion and xAI at $50 to $100 billion.

That produces approximately $1.3 to $1.35 trillion in gross assets, and after accounting for exercise costs, taxes, and loans, net worth hovers just below, but may not surpass, the $1 trillion mark.

By comparison, if Ethereum were valued at $5,000 with 125 million coins, the market cap would be approximately $625 billion.

In a base case, Tesla reaches $5 trillion, Optimus works first in factories, and energy scales, putting Musk’s Tesla stake at around $1.25 to $1.45 trillion, with SpaceX at $1 trillion and xAI at $200 billion.

That configuration makes a trillion-dollar net worth a base outcome, while Ethereum, even at nearly $10,000 and with 120 to 125 million coins, places ETH’s value around $1.2 to $1.25 trillion.

In a bull case, Tesla reaches a market capitalization of $8.5 trillion, robotaxis are widely adopted, humanoids are shipped at scale, SpaceX advances toward a market capitalization of $2.5 trillion, and xAI surpasses $500 billion. Musk’s wealth becomes multi-trillion.

The comparison is not hero versus protocol; it is equity optionality versus network adoption.

Scenario (2030–2035)Tesla Market CapImplied Musk Tesla StakeSpaceX / xAIGross AssetsPlausible Net WorthETH SupplyETH PriceETH Market CapKey AssumptionsConservative$3T~$750B$500B / $50–100B~$1.3–1.35TSub-$1T–$1.1T~125M$5k~$625BRobotaxi limited geography, Optimus niche, ETF demand steadyBase$5T~$1.25–$1.45T$1T / $200B~$2.45–$2.65T>$1T120–125M$10k~$1.2–$1.25TPartial autonomy monetization, Optimus in factories, ETF penetrationBull$8.5T~$2.1–$2.5T$2.5T / $0.5T+$5T+Multi-trillion~120M$20k~$2.4TBroad robotaxis, humanoid scale, crypto supercycleSo, for Ethereum to surpass Musk within the next decade and reach a $1 trillion valuation first, ETH would need to break above $10,000, assuming Tesla’s market cap remains below $3 trillion.

Billionaire influence and the politics of wealthHowever, I believe that the social framing around these numbers also matters.

Research published through Cambridge University Press shows that admiration for the mega-rich, and related meritocracy or system-justifying beliefs, reduces support for redistribution and progressive taxation, including among lower-income groups.

Long-term research in political science suggests that policy outcomes are more responsive to the preferences of affluent individuals than to those of average citizens, indicating that extreme concentration can lead to enduring political influence.

In parallel, studies in economics have found that exposure to wealthier peers lowers life satisfaction and increases conspicuous consumption and borrowing, with significant effects at the lower end of the distribution, as documented in the Quarterly Journal of Economics and related work.

Polling by the Harris Poll in 2024 shows majorities say billionaires do not do enough for society, and UK polling points to broad concern about the political reach of the very rich.

These are not abstract vibes around celebrity. They are channels through which billionaire glamor and media narratives feed back into budgets, ballots, and debt.

Context on scale helps locate the ethics.Forbes counted 3,028 billionaires in 2025, a record high, out of a world population of roughly 8.23 billion, which means about one in 2.7 million people.

No trillionaire currently exists. UBS estimates global household wealth at $450 trillion. One trillion dollars is about 0.22 percent of that total. The median adult wealth globally is in the low thousands of dollars, and more than 80 percent of adults have less than $100,000, according to Reuters’ summary of UBS data.

A one trillion-dollar personal fortune would equal the entire net worth of approximately 100 to 130 million median adults. The base rate for anyone moving from millionaire to billionaire is vanishingly low. Treating a trillion as an aspirational target for the public is numerically incoherent.

Policy choices are the swing factor around the tail. Status quo rules let top-end fortunes compound, and given the documented tilt in policy responsiveness, affordability issues tend to lag behind.

A targeted 2 percent annual tax on billionaire wealth, as modeled by Zucman and cited by Oxfam and reported by The Washington Post, would raise approximately $250 billion per year, which could fund public goods or cost-of-living relief while modestly trimming the tail.

A cultural shift away from grand man narratives and toward systemic accounts of progress raises support for progressive taxation in experimental settings, creating a softer check on the spillovers of billionaire worship.

Policy and public perception shape the trillion-dollar raceNone of these measures changes Tesla’s valuation math or crypto demand curves on their own. They adjust the environment in which extreme fortunes sit.

There is also a governance angle within Tesla. Shareholders, not just the board, priced the option convexity and approved it, which answers one critique while raising another.

If state permits and safety agencies effectively gate the autonomy cash flows that underpin the plan, then public oversight now sits upstream of private wealth options worth trillions.

According to Reuters and California DMV records, Tesla still requires driverless testing and deployment approvals for the robotaxi scale in key markets, and NHTSA reviews remain active. The calendar for those decisions, not press events, will determine whether the package converts.

We do not need to cheer or boo Musk to see the comparison cleanly.

A monetary network’s path to one or two trillion relies on adoption, throughput, and flows. In contrast, a founder’s path to one or more trillion relies on a narrow set of technical and regulatory unlocks.

One can admire execution or engineering without celebrating a culture of billionaire worship that blunts support for redistribution and amplifies the sway of elites over policy. The math is plain, the worship is optional.

Ultimately, whether the first to reach $1 trillion is a man or a network, the more important question is what kind of system we want to empower: one built on individual ambition or collective adoption?

Mentioned in this article

The crypto market just experienced one of its most volatile weeks of 2025. Bitcoin briefly dropped below $100,000, wiping out nearly $2 billion in market value within hours and sending a wave of fear across investors.

XRP Outperforms Bitcoin as ETF Filings Enter 20-Day Window, Setting up Breakout Trade to $2.80XRP's price action shows strong institutional interest, with significant volume increases and new wallet creations.Updated Nov 8, 2025, 4:40 a.m. Published Nov 8, 2025, 4:39 a.m.

What to know: XRP surged 3.6% to $2.31, breaking key resistance at $2.28, driven by ETF momentum and network growth.Canary Capital Group's amended prospectus for its proposed XRP ETF moves closer to potential SEC approval.XRP's price action shows strong institutional interest, with significant volume increases and new wallet creations.XRP climbed 3.6% to $2.31 in Saturday trading, breaking above key resistance at $2.28 as ETF momentum and network growth drove renewed institutional interest. Volume surged 86% above the 24-hour average during the breakout, lifting the token to its strongest close in over a week while outperforming Bitcoin and Ethereum amid subdued broader market activity.

News BackgroundCanary Capital Group filed an amended prospectus for its proposed Canary XRP ETF, moving the fund closer to potential SEC approval under Section 8(a).The ETF would trade on Nasdaq under ticker XRPC and hold XRP in custody with Gemini Trust Company and BitGo Trust Company, using the CoinDesk XRP CCIXber 60m New York Rate as its pricing benchmark.The filing follows a parallel move by 21Shares, which triggered an automatic-effectiveness countdown for its own spot XRP ETF. Bloomberg’s Eric Balchunas noted that dual filings could force the SEC’s first decision on XRP-based ETFs, echoing precedents set by approved Bitcoin and Ether products. The filings add to a week of expanding institutional focus on Ripple, which also announced new partnerships with Mastercard and WebBank for RLUSD settlement.Price Action SummaryXRP traded within a $0.19 range, gaining strength after clearing resistance at $2.22 and $2.28 in a single high-volume move at 16:00 UTC. The breakout occurred on 165M volume, marking an 86% jump over daily averages and confirming institutional participation.Price action consolidated between $2.32–$2.35, holding higher lows and signaling controlled accumulation by larger traders. Hourly charts showed repeated defenses at $2.309–$2.310, where buyers absorbed every dip, while brief volatility spikes to $2.324 indicated strong order-book liquidity at new support levels.Technical AnalysisThe breakout above $2.28 confirmed the end of short-term compression, with RSI turning upward and MACD crossing into positive territory. The higher-low structure established a bullish channel with immediate resistance at $2.35–$2.40.On-chain data supported the move, showing 21,595 new XRP wallets created within 48 hours — the largest increase in eight months — alongside mixed whale behavior. Roughly 900,000 XRP were transferred to exchanges over five days, suggesting potential short-term supply pressure, though net exchange reserves remain historically low.Volume divergence between the breakout and subsequent consolidation implies institutional repositioning rather than speculative momentum, keeping bias moderately bullish above $2.27.What Traders Should KnowXRP’s ability to hold above $2.30 will determine whether the current breakout evolves into a sustained leg higher. A confirmed close above $2.35 could extend the move toward $2.54–$2.80, while failure below $2.27 risks retesting the $2.13–$2.15 zone.Traders continue to monitor ETF progress as a near-term volatility trigger. If Canary’s registration passes automatically under 8(a) rules, XRP could become the next major asset with U.S.-listed spot exposure — a development that may accelerate institutional demand and price discovery heading into Q4.More For You

Inside Zcash: Encrypted Money at Planetary Scale

Nov 3, 2025

A deep dive into Zcash's zero-knowledge architecture, shielded transaction growth, and its path to becoming encrypted Bitcoin at scale.

What to know:

In 2025, Zcash evolved from niche privacy tech into a functioning encrypted-money network:

Shielded adoption surged, with 20–25% of circulating ZEC now held in encrypted addresses and 30% of transactions involving the shielded pool.The Zashi wallet made shielded transfers the default, pushing privacy from optional to standard practice.Project Tachyon, led by Sean Bowe, aims to boost throughput to thousands of private transactions per second.Zcash surpassed Monero in market share, becoming the largest privacy-focused cryptocurrency by capitalization.View Full Report

More For You

Crypto Markets Manage Modest Move Higher Friday, Trimming Weekly Losses

8 hours ago

Fully satiated shorts were likely booking some profits, but there was a bit of bullish news on the tape as well.

What to know:

Crypto markets are on track to end a difficult weak with some gains.Shorts are likely booking some profits after large declines earlier in the week.Economic data suggests a December Fed rate cut could be very much back on the table.Read full story

Top Stories

Polkadot’s price action is beginning to hint at a possible shift in momentum, with a reversal setup forming just below the critical $2.85 level. The bulls are gradually building pressure, eyeing a breakout that could confirm a change in trend. Still, the presence of strong resistance overhead means the coming sessions will be crucial in determining whether DOT can break free or face another rejection.

DOT’s Downtrend Shows Signs Of Exhaustion As Buyers Eye A Short-Term Recovery
Giving a follow-up on the expected path of DOT in the 4-hour timeframe, Elliott Waves Academy revealed that the series of declines through the sub-waves of the recent impulsive move may be nearing its end. This suggests that the current downward trend is exhausting itself, at least in the short term, with a potential recovery ahead.

Related Reading: Polkadot Recovery Stalls As Bearish Pressure Returns With $3.5 In Sight

Elliott Waves Academy observes that a diagonal pattern appears to be forming, which is outlining the intricate details of wave (1)/(A). This diagonal formation is key to the analysis, as it typically signals the termination of a prior trend and precedes a reversal.

Source: Chart from Elliot Wave Academy on X
The analyst points to a confirmed break above the upper boundary of this diagonal pattern. Such a break would officially open the path for an upward recovery toward the zone between $3.3423 and $3.36538.

On the other hand, the $2.2848 level is deemed crucial for maintaining the immediate recovery outlook. Elliott Waves Academy warned that if this critical $2.2848 level is broken, further significant downside is expected through an extension of the existing bearish waves.

Polkadot Remains Trapped Beneath Major HTF Resistance Levels
Crypto_Jobs shared on X that the long-term chart for Polkadot remains largely stagnant and constrained beneath major high-timeframe (HTF) resistance zones at $3.200 and $3.780. The analyst cautioned traders to remain conservative with any swing (long) setups while the price trades below these critical resistance barriers.

Examining the current price action, Crypto_Jobs described market conditions as neutral, with Polkadot fluctuating within a tight range between $2.500 and $2.700. The sideways movement reflects a lack of clear direction, as both bulls and bears struggle for dominance. Despite this period of indecision, the chart showcases an emerging pattern that could soon dictate the next significant move.

The crypto analyst noted the possible formation of an inverse head and shoulders pattern, with a neckline around the $2.700–$2.850 to $3.00 zone. A confirmed breakout above this neckline could signal renewed bullish momentum, potentially leading to a 5–10% price surge.

DOT trading at $2.7 on the 1D chart | Source: DOTUSDT on Tradingview.com
Featured image from Medium, chart from Tradingview.com

Circle, the issuer of the USDC stablecoin, has updated its terms of service to permit the use of its digital dollar token for lawful firearm purchases, reversing a previous restriction that had drawn criticism from gun rights advocates and U.S. lawmakers.

Cardano is showing early signs of life again after weeks of pressure, gaining nearly 5% to trade around $0.58. The bounce comes at a time when macroeconomic signals from the Federal Reserve are becoming increasingly confusing. With policymakers split on whether to cut interest rates again in December and inflation still running above target, risk assets like cryptocurrencies are treading carefully. For ADA price, this hesitation from the Fed could dictate how sustainable its short-term rally really is.

Cardano Price Prediction: How Fed Uncertainty Shapes the Market MoodThe market’s current hesitation stems from mixed messages out of the Federal Reserve. Some officials, including Austan Goolsbee, are urging caution, saying the lack of official economic data during the ongoing government shutdown makes it risky to ease further. Others, like Trump’s appointee Stephen Miran, are pushing for faster cuts to protect the job market.

This divergence has left traders guessing about whether the next rate move in December will bring relief or disappointment. For ADA and other altcoins, rate cut expectations are crucial because lower interest rates generally drive liquidity back into risk assets. But when the Fed’s message turns foggy, traders tend to de-risk—meaning ADA’s upside momentum could face short-lived resistance if the uncertainty persists through mid-November.

Technical Analysis: Cardano Price Prediction Finds Short-Term SupportADA/USD Daily Chart- TradingViewThe daily chart shows ADA price consolidating after a deep correction through October. The coin has rebounded from near $0.50, forming a small bullish candle cluster within the lower Bollinger Band range. The 20-day moving average sits around $0.61, now acting as immediate resistance, while the upper Bollinger Band near $0.70 caps the next potential breakout zone.

The current move above $0.58 suggests buyers are cautiously re-entering the market. However, volume remains muted, and ADA is still trading below its mid-band average—indicating that the recovery lacks strong conviction. A sustained close above $0.61 could open a path toward $0.68–$0.70, while failure to break that level may pull prices back to the $0.52–$0.50 support range.

Momentum Indicators Point to a Fragile ReversalThe Heikin Ashi candles have turned green for the first time since late October, hinting at an early trend reversal. Still, Cardano price remains in a broader downtrend channel, and the 50-day simple moving average is curling downward. The lower wick rejection around $0.50 aligns with the Fibonacci retracement zone of 0.382 from the August rally, suggesting that level could serve as a durable short-term floor if Bitcoin remains stable.

Bollinger Band contraction also indicates volatility compression, typically preceding a decisive breakout. If ADA price can hold above $0.57 for several sessions, a mid-month surge toward $0.68 is plausible. Otherwise, a sideways drift between $0.50 and $0.60 may continue until macro conditions clarify.

Macro Correlation: Why ADA Price Mirrors Fed TensionCrypto assets, particularly large-cap altcoins like ADA, tend to shadow broader risk sentiment. When the Fed hints at policy easing, Cardano price often benefits from renewed speculative flows. However, with inflation data unclear and rate cuts now uncertain, investors are turning selective, focusing on tokens with clearer development milestones or staking utility.

In Cardano’s case, network fundamentals remain strong, but speculative traders are waiting for a clear macro trigger. If the Fed signals even a slight dovish tilt in late November, ADA could see renewed accumulation targeting the $0.70–$0.75 range by December.

ADA Price Forecast for November 2025Based on the current chart setup and macro backdrop:

Bullish scenario: A break above $0.61–$0.63 confirms short-term momentum, allowing ADA price to retest $0.70. Sustained buying could extend gains to $0.75 by the month’s end if the Fed hints at further rate cuts.Neutral scenario: ADA price stays range-bound between $0.50 and $0.60, consolidating before a December breakout.Bearish scenario: Failure to hold $0.52 could trigger another leg down to $0.45 if risk sentiment worsens or if the Fed turns more hawkish.Given current conditions, ADA’s likely path is a gradual recovery toward $0.65, but the move hinges on how the Fed resolves its internal divide.

Cardano’s November rebound is promising but fragile. Technical signals suggest a mild recovery phase, while macro uncertainty keeps traders defensive. Until the Federal Reserve provides clarity on rate cuts, $ADA is likely to trade in a cautious range. The next few weeks will determine whether this bounce marks the start of a new uptrend—or just another pause before broader consolidation resumes.

📈 Want to Trade Cardano?Start now on Bitget: Sign Up Here
Check Live ADA Chart: ADA/USDT on Bitget

or You an check the Crypto Exchange Comparison.

Bitcoin’s latest market pullback has pushed its MVRV ratio back into a critical zone that has historically been associated with macro correction lows and early-stage recovery setups. The MVRV metric now reflects a valuation reset similar to the conditions that preceded major rebound phases in prior cycles.

Why The Reset Reinforces Bitcoin Value Proposition
The crypto bearish performance echoes through the Bitcoin community as the Market Value to Realized Value (MVRV) ratio dips into the critical 1.8 to 2.0 range, a zone significant for past cycle corrections where BTC found its footing before initiating a recovery. An ambassador and market expert, BitBull, has revealed on X that for those unfamiliar with its significance, the MVRV ratio compares BTC’s current market value to its realized value, which is what investors actually paid for their coins.

However, when this ratio dips near 2, it signals that a majority of holders are hovering around their cost basis. At this point, there’s no greed left in the system, just conviction. Historically, this 1.8 to 2.0 MVRV range has coincided with major market bottoms in June 2021, November 2022, and April 2025, when the market felt broken, but BTC was quietly resetting.

Source: Chart from BitBull on X
With the MVRV ratio currently re-entering this same critical zone, combined with the massive liquidations observed recently and a palpable sense of panic across the market, the pattern feels eerily familiar. Every time sentiment turns into hopelessness, on-chain data would show a different story of exhaustion, not collapse.

BitBull personally views this phase as one of compression, not capitulation, indicating short-term pain but a long-term opportunity. The same market dynamics cycle that previously punished excessive leverage is now washing out the remaining weak hands. BitBull concluded that if history rhymes, this will be the part of the story where the bottom gets written, not the top.

Why Liquidity Matters More Than Interest Rates
Liquidity has been a crucial component of the Bitcoin market. A full-time crypto trader and investor, Daan Crypto Trades, has pointed out that if there is one macro factor that drives BTC and the broader crypto market, it’s the amount of global liquidity within the financial system, not interest rates.

This correlation is clear from comparing the global liquidity index with BTC’s price movements over the years. Daan has recently observed a shift where global liquidity has stopped expanding and begun to trend downwards again. 

However, this change has put a halt to BTS’s upward momentum, combined with the anticipated profit-taking behavior observed during the 4-year market cycle. “Once global liquidity starts expanding at a rapid pace, the market environment for crypto will become significantly more supportive than it is currently,” the expert noted.

BTC trading at $101,684 on the 1D chart | Source: BTCUSDT on Tradingview.com
Featured image from Pixabay, chart from Tradingview.com

Strategy Inc. is accelerating its bitcoin accumulation with a bold €620 million euro-denominated stock offering, targeting stronger digital asset exposure, lucrative 10% yields, and compounded growth potential while reinforcing its position as the world's largest bitcoin treasury.